[ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system].
Lazebnik
L B
LB
Mikheeva
O M
OM
Komissarenko
I A
IA
Drozdov
V N
VN
Petrakov
A V
AV
Sil'vestrova
S Iu
SIu
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory; D004656:Enalapril / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D005234:Fatty Liver / Q000150:complications* / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017706:Lisinopril / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000150:complications* / Q000378:metabolism; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D017706:Lisinopril